TrialBritish journal of cancer2021

A miRNA signature predicts benefit from addition of hypoxia-modifying therapy to radiation treatment in invasive bladder cancer.

Mairah T Khan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.